Wealth Enhancement Advisory Services
TNDM icon

Wealth Enhancement Advisory Services’s Tandem Diabetes Care TNDM Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$407K Buy
26,438
+4,318
+20% +$75.4K ﹤0.01% 2889
2026
Q1 		$412K Buy
22,120
+3,427
+18% +$74.5K ﹤0.01% 2487
2025
Q4 		$440K Buy
18,693
+3,611
+24% +$65.2K ﹤0.01% 2580
2025
Q3 		$219K Buy
+15,082
New +$204K ﹤0.01% 3056

Other funds holding TNDM

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
RWA
Redhawk Wealth Advisors Minneapolis, Minnesota $1.02B AUM 35.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Wealth Enhancement Advisory Services's TNDM Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Tandem Diabetes Care (TNDM) stake by 20% in Q2 2026, buying an estimated $75.4K and bringing the position to 26,438 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #2889.

Wealth Enhancement Advisory Services first reported a position in TNDM in Q3 2025 and has held it in 4 quarters since. The position peaked at $440K in Q4 2025. 22 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Wealth Enhancement Advisory Services held 26,438 shares of Tandem Diabetes Care worth $407K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 4,318 Tandem Diabetes Care shares in Q2 2026, an estimated $75.4K.
  • Tandem Diabetes Care made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2889 holding.
  • Wealth Enhancement Advisory Services first reported a position in Tandem Diabetes Care in Q3 2025 and has held it in 4 quarters since.
  • Wealth Enhancement Advisory Services's Tandem Diabetes Care position peaked at $440K in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.